Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for IPSC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 119.71M
March 31, 2026 135.15M
December 31, 2025 117.91M
September 30, 2025 132.75M
June 30, 2025 155.84M
March 31, 2025 165.12M
December 31, 2024 189.29M
September 30, 2024 198.11M
June 30, 2024 196.40M
March 31, 2024 192.02M
December 31, 2023 172.74M
September 30, 2023 169.50M
Date Value
June 30, 2023 156.40M
March 31, 2023 251.47M
December 31, 2022 315.50M
September 30, 2022 355.86M
June 30, 2022 378.76M
March 31, 2022 361.02M
December 31, 2021 222.88M
September 30, 2021 295.15M
June 30, 2021 397.57M
March 31, 2021 183.32M
December 31, 2020 76.54M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Tenax Therapeutics, Inc. 117.98M
Manhattan Scientifics, Inc. --
Exicure, Inc. 1.717M
Absci Corp. 201.14M
Celularity, Inc. 6.175M